61 related articles for article (PubMed ID: 32050977)
1. A novel approach to quantify calcifications of thyroid nodules in US images based on deep learning: predicting the risk of cervical lymph node metastasis in papillary thyroid cancer patients.
Wang J; Dong C; Zhang YZ; Wang L; Yuan X; He M; Xu S; Zhou Q; Jiang J
Eur Radiol; 2023 Dec; 33(12):9347-9356. PubMed ID: 37436509
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract][Full Text] [Related]
3. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Chen W; Yu X; Li H; Yuan S; Fu Y; Hu H; Liu F; Zhang Y; Zhong S
Oral Oncol; 2024 Jan; 148():106654. PubMed ID: 38061122
[TBL] [Abstract][Full Text] [Related]
5. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI
Berinde GM; Socaciu AI; Socaciu MA; Petre GE; Socaciu C; Piciu D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542465
[TBL] [Abstract][Full Text] [Related]
7. The Immune Interplay between Thyroid Papillary Carcinoma and Hepatic Fibrosis.
Muhanna N; Amer J; Salhab A; Sichel JY; Safadi R
PLoS One; 2015; 10(7):e0132463. PubMed ID: 26151749
[TBL] [Abstract][Full Text] [Related]
8. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma.
Wang Z; Yang Y; Xing Y; Si D; Wang S; Lin J; Li C; Zhang J; Yin D
Sci Rep; 2023 Oct; 13(1):17666. PubMed ID: 37848492
[TBL] [Abstract][Full Text] [Related]
9. Stimulated Raman Scattering Microscopy Reveals Aberrant Triglyceride Accumulation in Lymphatic Metastasis of Papillary Thyroid Carcinoma.
Zeng J; Wu G; Jia H; Liu C; Liu C; Zhang Y; Liu S; Wang J; Yue S
Anal Chem; 2024 Apr; 96(15):5735-5740. PubMed ID: 38567982
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Status of HYAL1 in Malignant and Benign Thyroid Nodules.
Li M; Yin Y; Zhang M; Jiang C; Li H; Yang R
Horm Metab Res; 2023 Dec; 55(12):869-875. PubMed ID: 38040022
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma.
Li S; Chen Z; Liu M; Li L; Cai W; Lian ZX; Guan H; Xu B
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38214937
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer.
Buczyńska A; Sidorkiewicz I; Kościuszko M; Adamska A; Siewko K; Dzięcioł J; Szumowski P; Myśliwiec J; Szelachowska M; Popławska-Kita A; Krętowski A
Sci Rep; 2023 Aug; 13(1):13711. PubMed ID: 37608150
[TBL] [Abstract][Full Text] [Related]
13. Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics.
Lu H; Pan Y; Ruan Y; Zhu C; Hassan HM; Gao J; Gao J; Fan L; Liang X; Wang H; Ying S; Chen Q
J Proteome Res; 2023 Oct; 22(10):3200-3212. PubMed ID: 37624590
[TBL] [Abstract][Full Text] [Related]
14. New biomarkers: prospect for diagnosis and monitoring of thyroid disease.
Macvanin MT; Gluvic ZM; Zaric BL; Essack M; Gao X; Isenovic ER
Front Endocrinol (Lausanne); 2023; 14():1218320. PubMed ID: 37547301
[TBL] [Abstract][Full Text] [Related]
15. TFE3 Regulates the Function of the Autophagy-Lysosome Pathway to Drive the Invasion and Metastasis of Papillary Thyroid Carcinoma.
Lu H; Zhu C; Ruan Y; Fan L; Wei K; Yang Z; Chen Q
Anal Cell Pathol (Amst); 2021; 2021():3081491. PubMed ID: 34660181
[TBL] [Abstract][Full Text] [Related]
16. TROP2 modulates the progression in papillary thyroid carcinoma.
Sun H; Chen Q; Liu W; Liu Y; Ruan S; Zhu C; Ruan Y; Ying S; Lin P
J Cancer; 2021; 12(22):6883-6893. PubMed ID: 34659576
[No Abstract] [Full Text] [Related]
17. Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma.
Lu H; Zhang L; Dai Y; Ruan Y; Cao X; Cai X; Ruan S; Chen Q
Diagn Pathol; 2020 Feb; 15(1):16. PubMed ID: 32050977
[TBL] [Abstract][Full Text] [Related]
18. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
